0001708138-21-000048.txt : 20210810
0001708138-21-000048.hdr.sgml : 20210810
20210810170559
ACCESSION NUMBER: 0001708138-21-000048
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210806
FILED AS OF DATE: 20210810
DATE AS OF CHANGE: 20210810
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHLEIFER LEONARD S
CENTRAL INDEX KEY: 0001218629
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 211160939
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2021-08-06
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001218629
SCHLEIFER LEONARD S
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
1
0
0
President & CEO
Common Stock
2021-08-06
4
M
0
240000
52.03
A
573321
D
Common Stock
2021-08-06
4
F
0
137145
607.51
D
436176
D
Common Stock
2021-08-06
4
M
0
160000
52.03
A
596176
D
Common Stock
2021-08-06
4
F
0
91430
607.51
D
504746
D
Common Stock
2021-05-19
5
G
0
41178
0.0
A
41178
I
By Trust
Common Stock
2021-05-19
5
G
0
41178
0.0
D
0
I
by 2019 GRAT
Common Stock
200000
I
2021 GRAT
Common Stock
5874
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
52.03
2021-08-06
4
M
0
240000
0.0
D
2021-12-16
Common Stock
240000
160000
D
Non-Qualified Stock Option (right to buy)
52.03
2021-08-06
4
M
0
160000
0.0
D
2021-12-16
Common Stock
160000
0
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
These shares are held in a trust for the benefit of the reporting person's family members. The reporting person's spouse is a trustee of the trust.
With respect to 240,000 underlying shares (of which 0 remain outstanding), the option became exercisable on December 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2014. With respect to 160,000 underlying shares (of which 0 remain outstanding), the stock option award vested in four equal annual installments, commencing one year after the date of grant.
/s/**Leonard S. Schleifer
2021-08-10